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Abstract 
Background: Cancer is a leading cause of death. Rubia cordifolia is a 
traditional ayurvedic medicine being used as a remedy for various ailments. 
Results: Dichloromethane fraction of Rubia cordifolia extract exhibited 
potent inhibition of human leukaemia cell line and human histolytic 
lymphoma cell line while was found to be lesser active against normal human 
kidney cells displaying safety for normal cells. Conclusion: Rubia cordifolia 
can be a source of potent pharmacophore for treatment of disease like cancer. 
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Introduction 
Cancer is a dreadful disease and any practical 
solution in combating this disease is of 
paramount importance to public health [6]. Plants 
have been used as folk remedies and 
ethnobotanical literature has described the usage 
of plant extracts [7]. There is an increasing need 
for search of new compounds with cytotoxic 
activity as the treatment of cancer with the 
available anticancer drugs is often unsatisfactory 
due to the problem cytotoxicity to the normal 
cells [7]. For the last few decades, phytochemical 
examination has been making rapid progress and 
herbal products are becoming popular as sources 
of plausible anticancer compounds [7]. 
Rubia cordifolia (Rubiaceae), also known as 
Indian Madder or Manjistha is traditionally used 
as anti-inflammatory, antiseptic and 
galactopurifier but its anticancer property is yet 
not known. 
 
Material and methods 
Reagents 
 
 
 
Trypan blue (Hyclone), Triton X100 (MP 
Biomedicals), DMSO cell culture grade (MP 
Biomedicals), Sodium bicarbonate (MP 
Biomedicals), HYQ® Antibiotic/Antimycotic 
solution, 100X (10000 U/ml Penicillin 
G,10000µg/ml Streptomycin, 25 µg/ml 
Amphotericin B) (Hyclone), Penicillin and 
Streptomycin solution (MP Biomedicals), EDTA 
(MP Biomedicals), HYQ® DPBS/modified 1X 
(Dulbecoo’s phosphate buffer saline without Ca+ 
& Mg+) (Hyclone), 0.25% Trypsin 1X 
(Invitrogen), Cyclophosphamide monohydrate 
(MP Biomedicals), HBSS –1X (Hank’s Balanced 
Salt solution) (Hyclone), Cell proliferation kit 
(XTT) 2500 tests (Roche), Ethanol, Methanol, 
Petroleum ether, Dichloromethane.  
 
Media 
DMEM (Dulbecoos Modified Eagels medium, 
low glucose with glutamine) (US Biological), 
RPMI1640 (with L-glutamine) (Hyclone,), FBS 
(Fetal   Bovine  Serum,  South  American  origin) 
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(Bioclot), HYQ® SFM HEK-293TM (Hyclone). 
 
Cell lines 
HEK 293 (Human Epithelial Kidney cell line), 
U937 (Human Histolytic lymphoma cell line), 
HL 60 (Human Myeloid leukemia cell line), all 
cell lines were purchased from NCCS: National 
Center for Cell Science, Pune. 
 
Collection and Preparation of Plant Material 
The plant sample (roots) of Rubia cordifolia was 
purchased from Yucca enterprise, Mumbai. For 
taxonomical identification, it was authenticated 
by Mr. V.R.Patel (Dept. of Pharmacognosy, 
Baroda college of Pharmacy, Vadodara). After 
proper identification, the plant samples were cut 
into small pieces followed by dried and grinded 
into coarse powder by using high capacity 
grinding machine and passed through sieve 
number 14. It was stored in an airtight container. 
 
Extraction and Fractionation Procedure 
500 g of dried powder of Rubia cordifolia was 
soaked into ethanol and boiled at 80ºC for 3 
hours to get crude ethanol extracts. The extract 
was then filtered through cotton followed by 
Whatman No.1 filter paper and the filtrate thus 
obtained was concentrated at 40ºC with a rotary 
evaporator (Rotaver). The concentrated extract 
was dried residue. The yield of the extract was 
38.4 g. The crude extract was then dissolved in 
10% water in methanol (100 ml) and partitioned 
between pet-ether (2.8 g), dichloromethane (4.2 
g) and methanol fractions (22.9 g) [5]. 
 
Experimental design   
A cytotoxicity property of extracts of roots of 
Rubia Cordifolia was carried out by XTT method 
against HEK293, HL60, and U937 cell lines. 2 
mg of each plant extract was dissolved in 200µl 
of DMSO (dimethyl sulfoxide) then 100µl of this 
solution was diluted to 10ml with DMEM 
(Dulbecoos Modified Eagels medium, low 
glucose with glutamine). Thus, final 
concentration of this stock solution was 
100µg/ml. Then by serial dilution varying 
concentrations were prepared from the stock 
solution. Thus the concentrations of the solutions 
obtained were 100 µg/ml, 33.33 µg/ml, 11.11 
µg/ml, 3.70 µg/ml, 1.23 µg/ml, 0.411 µg/ml, 
0.137 µg/ml, 0.045 µg/ml, 0.015 µg/ml, 0.005 
µg/ml. 2 mg of Cyclophosphamide monohydrate 
(served as the positive control) was dissolved in 
200µl of DMSO (dimethyl sulfoxide) then 100µl 
of this solution was diluted to 10ml with DMEM 
(Dulbecoos Modified Eagels medium, low 
glucose with glutamine). Thus, final 
concentration of this stock solution was 
100µg/ml. Then by serial dilution varying 
concentrations were prepared from the stock 
solution. Thus the concentrations of the solutions 
obtained were 100 µg/ml, 33.33 µg/ml, 11.11 
µg/ml, 3.70 µg/ml, 1.23 µg/ml, 0.411 µg/ml, 
0.137 µg/ml, 0.045 µg/ml, 0.015 µg/ml, 0.005 
µg/ml. As for negative control 100µl of DMSO 
was diluted to 10 ml with DMEM (Dulbecoos 
Modified Eagels medium, low glucose with 
glutamine) [5]. 
Cells were preincubated at a concentration of 1× 
106 cells/ml in culture medium for 3 h at 37°C 
and 5% CO2. Cells were seeded at a 
concentration of 5× 104 cells/well in 100 µl 
culture medium and various amounts of 
compound (final concentration e.g. 100µM - 
0.005µM) into microplates (tissue culture grade, 
96 wells, flat bottom). Cell cultures were 
incubated for 24 h at 37°C and 5% CO2. 50 µl 
XTT labeling mixture was added and incubated 
for 18 h at 37°C and 6.5% CO2. The 
spectrophotometrical absorbance of the samples 
was measured using a microplate (ELISA) reader. 
The wavelength to measure absorbance of the 
formazan product was 450 nm according to the 
filters available for the ELISA reader, used. The 
reference wavelength was more than 650 nm [2-
4].   
All experiments were performed using three 
wells for each concentration of each compound 
tested. The cytotoxicity data was standardized by 
determining absorbance and calculating the 
correspondent compound concentrations. Dose 
response curve was developed for each 
concentration of each compound tested. IC50 
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value was determined for each concentration of 
each compound tested [1].    
 
Table.1 IC50 values (µg/ml) of standard 
Cyclophosphamide monohydrate and three 
different extracts of Rubia cordifolia (Rubiaceae) 
against HEK 293, U937 and HL60 cell lines. 
 
IC50 Values (µg/ml) 
Cell lines used 
Sample 
HEK293 HL 60 U937 
Cyclophosphamide 
monohydrate* 
>100 0.543 0.781 
Dichloromethane fraction >100 16.72 41.59 
Methanol fraction >100 8.57 27.23 
Pet-ether fraction >100 10.51 35.44 
         *(Positive control) 
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Figure 1. Graphical representation of IC50 
values (µg/ml) of standard Cyclophosphamide 
monohydrate and three different extracts of 
Rubia cordifolia (Rubiaceae) against HEK 293, 
U937 and HL60 cell lines. 
 
Result and discussion 
In this in vitro cytotoxicity assay, the root extract 
of Rubia cordifolia, exhibited significant 
cytotoxic activity against HL60 cell line with IC50 
values of 8.57 μg/ml, 10.51 μg/ml and 16.72 
μg/ml for methanol fraction, pet-ether fraction 
and dichloromethane fraction respectively, where 
moderate cytotoxicity was shown against U937 
cell line with IC50 values of 27.33 μg/ml, 35.44 
μg/ml, 41.59 μg/ml for methanol fraction, pet-
ether fraction and dichloromethane fraction 
respectively. None of the fraction of the extract 
was found to be cytotoxic against HEK293 cell 
line in the concentration range of 0.05-100 μg/ml. 
 
Conclusion 
Study results (Table 1) show that root extracts of 
Rubia Cordifolia is promisingly cytotoxic and 
they might have antitumor activity against 
myeloid leukemia and Histolytic lymphoma. 
None of the fraction of the extract was found to 
be cytotoxic against the normal cell line 
(HEK293) in the given range of concentration. 
So, this plant extracts may have clinical and 
therapeutic proposition in the most life threaten 
disease like cancer and further studies are 
required to investigate this plant as source of 
antineoplastic agents. 
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